WESTBROOK, Maine, May 24, 2011 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced the appointment of George Fennell as Corporate Vice President, General Manager, North American Companion Animal Group Customer Facing Organization, effective May 31.

Mr. Fennell joins IDEXX from Pfizer, Inc., where he recently served for five years as Vice President, U.S. Companion Animal Division of Pfizer Animal Health, leading its overall sales, marketing and technical operations functions.

“George is a seasoned executive in companion animal healthcare and brings to our team extensive sales and marketing experience and great customer insight, making him an excellent fit for this role,” said Jonathan Ayers, Chairman and CEO. “As a member of the leadership team at IDEXX, George will play a key role in driving our continued growth in the North American companion animal health market through innovation and great commercial execution.”

“I am very excited to be part of the IDEXX team at this time of incredible opportunity in the animal health market,” said Fennell. “IDEXX’s unique market position as a leader in diagnostic and information technology presents many opportunities to enhance the practice of veterinary medicine, the health of pets, and the satisfaction of pet owners.”

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,800 people and offers products to customers in over 100 countries.

Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155

SOURCE IDEXX Laboratories, Inc.